Innovators cannot afford to be bystanders as stakeholder perceptions of AOMs are being formed, especially with the AOM market at the cusp of becoming more crowded and competitive
Order today to enjoy fast delivery and expert advice on usage
Palatin announces the initiation of a Phase 2 clinical study of Bremelanotide co-administered with a PDE5i for the treatment of erectile dysfunction (ED)
The brain struggles to shut down under high cortisol and starch helps buffer that The tool: stop eating 3 hours before you go to sleep Eating activates the sympathetic nervous system
For those on a weight loss journey, one of the potential side effects of having more energy from having higher vitamin B12 levels is an increase in activity, which can result in a drop on the scale
Cagrilintide is further along: it has phase 3 monotherapy data, a dedicated phase 3 programme, and it is the amylin half of CagriSema, which Novo Nordisk filed with the FDA in December 2025